{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:33Z","timestamp":1710460833975},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/gme.0b013e3181924701","type":"journal-article","created":{"date-parts":[[2009,1,8]],"date-time":"2009-01-08T08:14:53Z","timestamp":1231402493000},"page":"5-7","source":"Crossref","is-referenced-by-count":7,"title":["Vulvovaginal atrophy"],"prefix":"10.1097","volume":"16","author":[{"given":"James A.","family":"Simon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210227","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jama.288.6.748","article-title":"The importance of the journal embargo.","volume":"288","author":"Phil","year":"2002","journal-title":"JAMA"},{"key":"R2-3-20210227","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"R4-3-20210227","first-page":"1107","article-title":"Postmenopausal Women's Attitudes: Vulvovaginal Atrophy and It's Symptoms. Dallas, TX: The North American Menopause Society (NAMS), Abstract no. LB-10.","volume":"14","author":"Simon","year":"2007","journal-title":"Menopause"},{"key":"R5-3-20210227","first-page":"369","article-title":"The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.","volume":"357-","year":"2007","journal-title":"Menopause"},{"key":"R6-3-20210227","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/gme.0b013e31817b6132","article-title":"Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.","volume":"16","author":"Labrie","year":"2009","journal-title":"Menopause"},{"key":"R7-3-20210227","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/annonc\/mdj127","article-title":"Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors.","volume":"17","author":"Kendall","year":"2006","journal-title":"Ann Oncol"},{"key":"R8-3-20210227","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.fertnstert.2007.07.1359","article-title":"A randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.","volume":"90","author":"Simon","year":"2008","journal-title":"Fertil Steril"},{"key":"R9-3-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/AOG.0b013e31818aa7c3","article-title":"Effective treatment of vaginal atrophy with an ultra-low dose estradiol vaginal tablet.","volume":"112","author":"Simon","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R12-3-20210227","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.GME.0000077620.13164.62","article-title":"Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.","volume":"11","author":"Dessole","year":"2004","journal-title":"Menopause"},{"key":"R13-3-20210227","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0378-5122(91)90092-5","article-title":"Efficacy of sustained-release vaginal oestriol in alleviating urogenital and systemic climacteric complaints.","volume":"13","author":"Foidart","year":"1991","journal-title":"Maturitas"},{"key":"R14-3-20210227","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM199309093291102","article-title":"A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.","volume":"329","author":"Raz","year":"1993","journal-title":"N Engl J Med"},{"key":"R17-3-20210227","first-page":"1230","article-title":"Intravaginal DHEA, the physiological and a highly efficient treatment of vaginal atrophy. Presented at: 19th Annual Meeting of The North American Menopause Society (NAMS). Is it menopause or is it aging? Orlando. Abstract no. LB-8.","volume":"15","author":"Labrie","year":"2008","journal-title":"Menopause"},{"key":"R18-3-20210227","first-page":"1208","article-title":"Comparison of serum estradiol levels following intravaginal estrogens and DHEA. Presented at: 19th Annual Meeting of The North American Menopause Society. Is it menopause or is it aging? Orlando. Abstract no. S-20.","volume":"15","author":"Labrie","year":"2008","journal-title":"Menopause"},{"key":"R19-3-20210227","first-page":"2757","article-title":"Serum lipid profile improved by ultra-low doses of 17 beta-estradiol in elderly women.","volume":"86","author":"Naessen","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-3-20210227","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9378(97)70448-4","article-title":"Bone loss in elderly women prevented by ultralow doses of parenteral 17b-estradiol.","volume":"177","author":"Naessen","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"R21-3-20210227","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1067\/mob.2002.122143","article-title":"Endometrial thickness and uterine diameter not affected by ultralow doses of 17beta-estradiol in elderly women.","volume":"186","author":"Naessen","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R22-3-20210227","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative Randomized Controlled Trial.","volume":"291","year":"2004","journal-title":"JAMA"},{"key":"R23-3-20210227","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/jnci\/dji400","article-title":"Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation.","volume":"97","author":"Lewis","year":"2005","journal-title":"JNCI"},{"key":"R24-3-20210227","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jsbmb.2004.12.032","article-title":"Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal.","volume":"94","author":"Lewis","year":"2005","journal-title":"J Steroid Biochem Molec Biol"},{"key":"R25-3-20210227","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1634\/theoncologist.2007-0234","article-title":"Should urogenital atrophy in breast cancer survivors be treated with topical estrogens?","volume":"13","author":"Trinkaus","year":"2008","journal-title":"Oncologist"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00042192-200916010-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:31:27Z","timestamp":1618277487000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-200916010-00003"}},"subtitle":["new and upcoming approaches"],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e3181924701","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}